Sunday 26 December 2010

Omicool-DXR




Omicool-DXR may be available in the countries listed below.


Ingredient matches for Omicool-DXR



Domperidone

Domperidone is reported as an ingredient of Omicool-DXR in the following countries:


  • India

Omeprazole

Omeprazole is reported as an ingredient of Omicool-DXR in the following countries:


  • India

International Drug Name Search

Friday 24 December 2010

Wysolone




Wysolone may be available in the countries listed below.


Ingredient matches for Wysolone



Prednisolone

Prednisolone is reported as an ingredient of Wysolone in the following countries:


  • India

International Drug Name Search

Thursday 23 December 2010

Diethylpropion




In the US, Diethylpropion (diethylpropion systemic) is a member of the following drug classes: anorexiants, CNS stimulants and is used to treat Obesity.

US matches:

  • Diethylpropion

  • Diethylpropion Controlled-Release Tablets

  • Diethylpropion Hydrochloride

Ingredient matches for Diethylpropion



Amfepramone

Diethylpropion (BAN) is also known as Amfepramone (Prop.INN)

International Drug Name Search

Glossary

BANBritish Approved Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 22 December 2010

Cinnarizina




Cinnarizina may be available in the countries listed below.


Ingredient matches for Cinnarizina



Cinnarizine

Cinnarizina (DCIT) is also known as Cinnarizine (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Lamotrigin Stada




Lamotrigin Stada may be available in the countries listed below.


Ingredient matches for Lamotrigin Stada



Lamotrigine

Lamotrigine is reported as an ingredient of Lamotrigin Stada in the following countries:


  • Austria

  • Denmark

  • Germany

  • Romania

International Drug Name Search

Monday 20 December 2010

Nevakson




Nevakson may be available in the countries listed below.


Ingredient matches for Nevakson



Ceftriaxone

Ceftriaxone is reported as an ingredient of Nevakson in the following countries:


  • Tunisia

  • Turkey

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Nevakson in the following countries:


  • Bosnia & Herzegowina

International Drug Name Search

Saturday 18 December 2010

Ometid




Ometid may be available in the countries listed below.


Ingredient matches for Ometid



Omeprazole

Omeprazole is reported as an ingredient of Ometid in the following countries:


  • Bangladesh

International Drug Name Search

Monday 13 December 2010

Omalcer




Omalcer may be available in the countries listed below.


Ingredient matches for Omalcer



Omeprazole

Omeprazole is reported as an ingredient of Omalcer in the following countries:


  • India

International Drug Name Search

Thursday 9 December 2010

Slow Trasicor




Slow Trasicor may be available in the countries listed below.


UK matches:

  • Slow Trasicor Tablets 160 mg (SPC)

Ingredient matches for Slow Trasicor



Oxprenolol

Oxprenolol hydrochloride (a derivative of Oxprenolol) is reported as an ingredient of Slow Trasicor in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 8 December 2010

Omeprazole Ratiopharm




Omeprazole Ratiopharm may be available in the countries listed below.


Ingredient matches for Omeprazole Ratiopharm



Omeprazole

Omeprazole is reported as an ingredient of Omeprazole Ratiopharm in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Lapimuc




Lapimuc may be available in the countries listed below.


Ingredient matches for Lapimuc



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Lapimuc in the following countries:


  • Indonesia

International Drug Name Search

Saturday 4 December 2010

Anfozan




Anfozan may be available in the countries listed below.


Ingredient matches for Anfozan



Etidronic Acid

Etidronic Acid disodium salt (a derivative of Etidronic Acid) is reported as an ingredient of Anfozan in the following countries:


  • Greece

International Drug Name Search

Friday 3 December 2010

Suigonan




Suigonan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Suigonan



Chorionic Gonadotrophin

Chorionic Gonadotrophin is reported as an ingredient of Suigonan in the following countries:


  • Finland

  • Germany

  • Norway

Gonadotrophin, Serum

Gonadotrophin, Serum is reported as an ingredient of Suigonan in the following countries:


  • Finland

  • Germany

  • Norway

International Drug Name Search

Friday 26 November 2010

Marzulene ES




Marzulene ES may be available in the countries listed below.


Ingredient matches for Marzulene ES



Glutamine

Glutamine is reported as an ingredient of Marzulene ES in the following countries:


  • Japan

Sodium Gualenate

Sodium Gualenate is reported as an ingredient of Marzulene ES in the following countries:


  • Japan

International Drug Name Search

Monday 22 November 2010

Dipropyline




Dipropyline may be available in the countries listed below.


Ingredient matches for Dipropyline



Alverine

Dipropyline (DCF) is also known as Alverine (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 18 November 2010

Tranexamsyra Orifarm




Tranexamsyra Orifarm may be available in the countries listed below.


Ingredient matches for Tranexamsyra Orifarm



Tranexamic Acid

Tranexamic Acid is reported as an ingredient of Tranexamsyra Orifarm in the following countries:


  • Sweden

International Drug Name Search

Wednesday 17 November 2010

Trizedon




Trizedon may be available in the countries listed below.


Ingredient matches for Trizedon



Trimetazidine

Trimetazidine dihydrochloride (a derivative of Trimetazidine) is reported as an ingredient of Trizedon in the following countries:


  • Indonesia

International Drug Name Search

Aloid




Aloid may be available in the countries listed below.


Ingredient matches for Aloid



Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Aloid in the following countries:


  • Mexico

International Drug Name Search

Acétylcysteine EG




Acétylcysteine EG may be available in the countries listed below.


Ingredient matches for Acétylcysteine EG



Acetylcysteine

Acetylcysteine is reported as an ingredient of Acétylcysteine EG in the following countries:


  • France

International Drug Name Search

Sunday 14 November 2010

Pacinone




Pacinone may be available in the countries listed below.


Ingredient matches for Pacinone



Halazepam

Halazepam is reported as an ingredient of Pacinone in the following countries:


  • Portugal

International Drug Name Search

Doan's




Ingredient matches for Doan's



Salicylic Acid

Salicylic Acid magnesium (a derivative of Salicylic Acid) is reported as an ingredient of Doan's in the following countries:


  • United States

International Drug Name Search

Wednesday 10 November 2010

Colchicine Houdé




Colchicine Houdé may be available in the countries listed below.


Ingredient matches for Colchicine Houdé



Colchicine

Colchicine is reported as an ingredient of Colchicine Houdé in the following countries:


  • Argentina

  • South Africa

  • Spain

International Drug Name Search

Sunday 7 November 2010

Melquin




In the US, Melquin (hydroquinone topical) is a member of the drug class topical depigmenting agents and is used to treat Dermatological Disorders.

US matches:

  • Melquin Cream

  • Melquin HP

  • Melquin-3

Ingredient matches for Melquin



Hydroquinone

Hydroquinone is reported as an ingredient of Melquin in the following countries:


  • United States

International Drug Name Search

Saturday 6 November 2010

Oftan Dexamethason




Oftan Dexamethason may be available in the countries listed below.


Ingredient matches for Oftan Dexamethason



Dexamethasone

Dexamethasone is reported as an ingredient of Oftan Dexamethason in the following countries:


  • Georgia

  • Russian Federation

International Drug Name Search

Friday 5 November 2010

Feminalin




Feminalin may be available in the countries listed below.


Ingredient matches for Feminalin



Ibuprofen

Ibuprofen is reported as an ingredient of Feminalin in the following countries:


  • Spain

International Drug Name Search

Thursday 4 November 2010

Erimin




Erimin may be available in the countries listed below.


Ingredient matches for Erimin



Nimetazepam

Nimetazepam is reported as an ingredient of Erimin in the following countries:


  • Japan

International Drug Name Search

Wednesday 3 November 2010

Gepeprostin




Gepeprostin may be available in the countries listed below.


Ingredient matches for Gepeprostin



Bicalutamide

Bicalutamide is reported as an ingredient of Gepeprostin in the following countries:


  • Argentina

International Drug Name Search

Ohsiat




Ohsiat may be available in the countries listed below.


Ingredient matches for Ohsiat



Afloqualone

Afloqualone is reported as an ingredient of Ohsiat in the following countries:


  • Japan

International Drug Name Search

Thursday 28 October 2010

Omeprazol-ratiopharm




Omeprazol-ratiopharm may be available in the countries listed below.


Ingredient matches for Omeprazol-ratiopharm



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol-ratiopharm in the following countries:


  • Austria

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • Germany

  • Hungary

  • Latvia

  • Lithuania

  • Netherlands

  • Portugal

  • Spain

  • Sweden

International Drug Name Search

PMS-Enalapril




PMS-Enalapril may be available in the countries listed below.


Ingredient matches for PMS-Enalapril



Enalapril

Enalapril is reported as an ingredient of PMS-Enalapril in the following countries:


  • Canada

International Drug Name Search

Tuesday 26 October 2010

Coverene




Coverene may be available in the countries listed below.


Ingredient matches for Coverene



Perindopril

Perindopril erbumine (a derivative of Perindopril) is reported as an ingredient of Coverene in the following countries:


  • Argentina

International Drug Name Search

Thursday 21 October 2010

Valsaprex




Valsaprex may be available in the countries listed below.


Ingredient matches for Valsaprex



Valsartan

Valsartan is reported as an ingredient of Valsaprex in the following countries:


  • Colombia

International Drug Name Search

Tuesday 19 October 2010

Oftinal




Oftinal may be available in the countries listed below.


Ingredient matches for Oftinal



Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Oftinal in the following countries:


  • Spain

International Drug Name Search

Monday 18 October 2010

Fluental




Fluental may be available in the countries listed below.


Ingredient matches for Fluental



Paracetamol

Paracetamol is reported as an ingredient of Fluental in the following countries:


  • Italy

Sobrerol

Sobrerol is reported as an ingredient of Fluental in the following countries:


  • Italy

International Drug Name Search

Linola H-Fett N




Linola H-Fett N may be available in the countries listed below.


Ingredient matches for Linola H-Fett N



Prednisolone

Prednisolone is reported as an ingredient of Linola H-Fett N in the following countries:


  • Czech Republic

  • Germany

  • Hungary

International Drug Name Search

Friday 15 October 2010

Duras




Duras may be available in the countries listed below.


Ingredient matches for Duras



Nandrolone

Nandrolone 17ß-decanoate (a derivative of Nandrolone) is reported as an ingredient of Duras in the following countries:


  • India

International Drug Name Search

Thursday 14 October 2010

Conclyte-Ca




Conclyte-Ca may be available in the countries listed below.


Ingredient matches for Conclyte-Ca



Calcium Chloride

Calcium Chloride is reported as an ingredient of Conclyte-Ca in the following countries:


  • Japan

International Drug Name Search

Monday 11 October 2010

Fluicor




Fluicor may be available in the countries listed below.


Ingredient matches for Fluicor



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Fluicor in the following countries:


  • Chile

International Drug Name Search

Thursday 7 October 2010

Tussafug




Tussafug may be available in the countries listed below.


Ingredient matches for Tussafug



Benproperine

Benproperine dihydrogen phosphate (a derivative of Benproperine) is reported as an ingredient of Tussafug in the following countries:


  • Germany

International Drug Name Search

Tuesday 5 October 2010

Rulicin




Rulicin may be available in the countries listed below.


Ingredient matches for Rulicin



Roxithromycin

Roxithromycin is reported as an ingredient of Rulicin in the following countries:


  • Japan

International Drug Name Search

Monday 27 September 2010

Qugyl-O




Qugyl-O may be available in the countries listed below.


Ingredient matches for Qugyl-O



Ofloxacin

Ofloxacin is reported as an ingredient of Qugyl-O in the following countries:


  • India

Ornidazole

Ornidazole is reported as an ingredient of Qugyl-O in the following countries:


  • India

International Drug Name Search

Clotopic




Clotopic may be available in the countries listed below.


Ingredient matches for Clotopic



Clotrimazole

Clotrimazole is reported as an ingredient of Clotopic in the following countries:


  • Peru

International Drug Name Search

Saturday 25 September 2010

Recalbon




Recalbon may be available in the countries listed below.


Ingredient matches for Recalbon



Minodronic Acid

Minodronic Acid is reported as an ingredient of Recalbon in the following countries:


  • Japan

International Drug Name Search

Friday 24 September 2010

Gynozol




Gynozol may be available in the countries listed below.


Ingredient matches for Gynozol



Clotrimazole

Clotrimazole is reported as an ingredient of Gynozol in the following countries:


  • Ethiopia

Ketoconazole

Ketoconazole is reported as an ingredient of Gynozol in the following countries:


  • Peru

Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Gynozol in the following countries:


  • Ethiopia

  • Romania

Tinidazole

Tinidazole is reported as an ingredient of Gynozol in the following countries:


  • Peru

International Drug Name Search

Tuesday 21 September 2010

Laxodate




Laxodate may be available in the countries listed below.


Ingredient matches for Laxodate



Sodium Picosulfate

Sodium Picosulfate monohydrate (a derivative of Sodium Picosulfate) is reported as an ingredient of Laxodate in the following countries:


  • Japan

International Drug Name Search

Monday 20 September 2010

Ocu-Cort


Generic Name: bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic (BAS i TRAY sin, NEE oh MYE sin, POL ee MIX in, HYE droe KOR ti sone off THAL mik)

Brand Names: Ocu-Cort


What is bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic?

Bacitracin, neomycin, and polymyxin B are antibiotics that kill bacteria.


Hydrocortisone is a steroid. It prevents the release of substances in the body that cause inflammation.


Bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic (for the eyes) is used to treat eye infections caused by bacteria, injury, burns, or contamination by a foreign body in the eye. This medication is also used to treat an eye condition called chronic uveitis.

Bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic?


You should not use this medication if you are allergic to bacitracin, neomycin, polymyxin B, or hydrocortisone. Do not use this medication if you have a fungal or viral infection that affects your eyes, including herpes, chickenpox, or smallpox.

Before using this medication, tell your doctor if you have glaucoma, cataracts, or a viral or fungal infection anywhere in your body.


Do not allow the tip of the ointment tube to touch any surface, including the eyes or hands. If the tip becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.

Use this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Bacitracin, neomycin, polymyxin B, and hydrocortisone will not treat a viral or fungal infection of the eye.


To make sure this medication is helping your condition and is not causing harmful effects, your eyes will need to be checked on a regular basis during treatment. This will help your doctor determine how long to treat you with bacitracin, neomycin, polymyxin B, and hydrocortisone. Do not miss any follow-up visits to your doctor.

Call your doctor if your symptoms do not improve, or if your infection gets worse while using this medication.


Bacitracin, neomycin, polymyxin B and hydrocortisone should not be used on a child.

What should I discuss with my healthcare provider before using bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic?


You should not use this medication if you are allergic to bacitracin, neomycin, polymyxin B, or hydrocortisone. Do not use this medication if you have a fungal or viral infection that affects your eyes, including herpes, chickenpox, or smallpox.

Before using bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic, tell your doctor if you have:



  • glaucoma;




  • cataracts; or




  • a viral or fungal infection anywhere in your body.




FDA pregnancy category C. It is not known whether bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Bacitracin, neomycin, polymyxin B and hydrocortisone should not be used on a child.

How should I use bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic?


Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


Wash your hands before using bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic ointment.


To use the ointment:



  • You may warm the ointment by holding the medicine tube in your hand for a few minutes before use. Do not remove the cap from the tube until you are ready to apply the ointment.




  • Tilt your head back slightly, and pull down gently on your lower eyelid. Apply a thin film of the ointment into your lower eyelid.




  • Close your eye and roll your eyeball around for 1 to 2 minutes.




Do not allow the tip of the ointment tube to touch any surface, including the eyes or hands. If the tip becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye. Do not share the ointment with another person.

Use this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Bacitracin, neomycin, polymyxin B, and hydrocortisone will not treat a viral or fungal infection of the eye.


To make sure this medication is helping your condition and is not causing harmful effects, your eyes will need to be checked on a regular basis during treatment. This will help your doctor determine how long to treat you with bacitracin, neomycin, polymyxin B, and hydrocortisone. You may need frequent eye exams if you use this medication for longer than 10 days. Do not miss any follow-up visits to your doctor.

Call your doctor if your symptoms do not improve, or if your infection gets worse while using this medication.


Store bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic at room temperature away from moisture and heat. Keep the tube tightly capped when not in use.

What happens if I miss a dose?


Use the medication as soon as you remember the missed dose. If it is almost time for your next dose, skip the missed dose and use the medicine at your next regularly scheduled time. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


An overdose of bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic is not likely to occur.


What should I avoid while using bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic?


Do not use any other eye medications unless your doctor has prescribed them.


Bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic can cause temporary blurred vision. Be careful if you drive or do anything that requires you to be able to see clearly.


Bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:

  • blurred vision, eye pain, or seeing halos around lights;




  • severe itching, watering, redness, or swelling of your eyes;




  • vision changes, increased sensitivity to light;




  • white patches on your eyes;




  • crusting or drainage from your eyes; or




  • any new signs of infection.



Less serious side effects may include temporary blurred vision and mild eye irritation after using the ointment.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic?


It is not likely that other drugs you take orally or inject will have an effect on bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic used in the eyes. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Ocu-Cort resources


  • Ocu-Cort Side Effects (in more detail)
  • Ocu-Cort Use in Pregnancy & Breastfeeding
  • Ocu-Cort Drug Interactions
  • Ocu-Cort Support Group
  • 0 Reviews for Ocu-Cort - Add your own review/rating


Compare Ocu-Cort with other medications


  • Conjunctivitis, Bacterial
  • Uveitis


Where can I get more information?


  • Your pharmacist can provide more information about bacitracin, neomycin, polymyxin B and hydrocortisone ophthalmic.

See also: Ocu-Cort side effects (in more detail)


Sunday 19 September 2010

Florexal




Florexal may be available in the countries listed below.


Ingredient matches for Florexal



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Florexal in the following countries:


  • Mexico

International Drug Name Search

Saturday 18 September 2010

Gasdol




Gasdol may be available in the countries listed below.


Ingredient matches for Gasdol



Domperidone

Domperidone is reported as an ingredient of Gasdol in the following countries:


  • Chile

International Drug Name Search

Tuesday 14 September 2010

Sitrox




Sitrox may be available in the countries listed below.


Ingredient matches for Sitrox



Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Sitrox in the following countries:


  • Argentina

International Drug Name Search

Sunday 12 September 2010

Procpen




Procpen may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Procpen



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Procpen in the following countries:


  • Netherlands

International Drug Name Search

Thursday 9 September 2010

Neolarmax




Neolarmax may be available in the countries listed below.


Ingredient matches for Neolarmax



Desloratadine

Desloratadine is reported as an ingredient of Neolarmax in the following countries:


  • Chile

International Drug Name Search

Wednesday 8 September 2010

Methylephedrine Hydrochloride




Methylephedrine Hydrochloride may be available in the countries listed below.


Ingredient matches for Methylephedrine Hydrochloride



Methylephedrine

Methylephedrine Hydrochloride (BANM) is also known as Methylephedrine (BAN)

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday 4 September 2010

Fluorescite


Fluorescite is a brand name of fluorescein, approved by the FDA in the following formulation(s):


FLUORESCITE (fluorescein sodium - injectable; intravenous)



  • Manufacturer: ALCON PHARMS LTD

    Approval date: March 28, 2006

    Strength(s): EQ 500MG BASE/5ML (EQ 100MG BASE/ML) [RLD][AP]

Has a generic version of Fluorescite been approved?


Yes. The following products are equivalent to Fluorescite:


AK-FLUOR 10% (fluorescein sodium injectable; intravenous)



  • Manufacturer: AKORN

    Approval date: August 8, 2008

    Strength(s): EQ 500MG BASE/5ML (EQ 100MG BASE/ML) [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fluorescite. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Fluorescite.

See also...

    Perioral Dermatitis Medications


    Definition of Perioral Dermatitis: Perioral dermatitis is a skin disorder characterized by tiny red bumps (papules) around the mouth.

    Drugs associated with Perioral Dermatitis

    The following drugs and medications are in some way related to, or used in the treatment of Perioral Dermatitis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    Learn more about Perioral Dermatitis





    Drug List:

    Friday 27 August 2010

    Ethasyl




    Ethasyl may be available in the countries listed below.


    Ingredient matches for Ethasyl



    Etamsylate

    Etamsylate is reported as an ingredient of Ethasyl in the following countries:


    • India

    International Drug Name Search

    Thursday 26 August 2010

    Osteod




    Osteod may be available in the countries listed below.


    Ingredient matches for Osteod



    Calcitriol

    Calcitriol is reported as an ingredient of Osteod in the following countries:


    • Czech Republic

    • Slovakia

    International Drug Name Search

    Saturday 21 August 2010

    Hexamidine Mylan




    Hexamidine Mylan may be available in the countries listed below.


    Ingredient matches for Hexamidine Mylan



    Hexamidine

    Hexamidine diisetionate (a derivative of Hexamidine) is reported as an ingredient of Hexamidine Mylan in the following countries:


    • France

    International Drug Name Search

    Thursday 19 August 2010

    Oponausée




    Oponausée may be available in the countries listed below.


    In some countries, this medicine may only be approved for veterinary use.

    Ingredient matches for Oponausée



    Dimenhydrinate

    Dimenhydrinate is reported as an ingredient of Oponausée in the following countries:


    • France

    International Drug Name Search

    Monday 16 August 2010

    Oxybutynin-MaxMedic




    Oxybutynin-MaxMedic may be available in the countries listed below.


    Ingredient matches for Oxybutynin-MaxMedic



    Oxybutynin

    Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynin-MaxMedic in the following countries:


    • Germany

    International Drug Name Search

    Etabus




    Etabus may be available in the countries listed below.


    Ingredient matches for Etabus



    Disulfiram

    Disulfiram is reported as an ingredient of Etabus in the following countries:


    • Mexico

    International Drug Name Search

    Saturday 14 August 2010

    Claryl




    Claryl may be available in the countries listed below.


    Ingredient matches for Claryl



    Clarithromycin

    Clarithromycin is reported as an ingredient of Claryl in the following countries:


    • Ireland

    International Drug Name Search

    Friday 6 August 2010

    Bioplacenton




    Bioplacenton may be available in the countries listed below.


    Ingredient matches for Bioplacenton



    Calcium Alginate

    Calcium Alginate is reported as an ingredient of Bioplacenton in the following countries:


    • Indonesia

    Neomycin

    Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Bioplacenton in the following countries:


    • Myanmar

    International Drug Name Search

    Wednesday 4 August 2010

    Nitrazepol




    Nitrazepol may be available in the countries listed below.


    Ingredient matches for Nitrazepol



    Nitrazepam

    Nitrazepam is reported as an ingredient of Nitrazepol in the following countries:


    • Brazil

    International Drug Name Search

    Monday 26 July 2010

    Pantopra-Q




    Pantopra-Q may be available in the countries listed below.


    Ingredient matches for Pantopra-Q



    Pantoprazole

    Pantoprazole sodium (a derivative of Pantoprazole) is reported as an ingredient of Pantopra-Q in the following countries:


    • Germany

    International Drug Name Search

    Saturday 24 July 2010

    A.N.B. Vitamin B1




    A.N.B. Vitamin B1 may be available in the countries listed below.


    Ingredient matches for A.N.B. Vitamin B1



    Thiamine

    Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of A.N.B. Vitamin B1 in the following countries:


    • Myanmar

    International Drug Name Search

    Wednesday 21 July 2010

    Anulacid




    Anulacid may be available in the countries listed below.


    Ingredient matches for Anulacid



    Pantoprazole

    Pantoprazole is reported as an ingredient of Anulacid in the following countries:


    • Peru

    International Drug Name Search

    Wednesday 14 July 2010

    Dolotec




    In the US, Dolotec is a member of the drug class miscellaneous analgesics and is used to treat Fever, Muscle Pain, Pain and Sciatica.

    Ingredient matches for Dolotec



    Paracetamol

    Paracetamol is reported as an ingredient of Dolotec in the following countries:


    • France

    International Drug Name Search

    Monday 12 July 2010

    Colpotrophine




    Colpotrophine may be available in the countries listed below.


    Ingredient matches for Colpotrophine



    Promestriene

    Promestriene is reported as an ingredient of Colpotrophine in the following countries:


    • Argentina

    • Burkina Faso

    • Cameroon

    • China

    • Congo

    • Cote D'ivoire

    • France

    • Gabon

    • Guinea

    • Hong Kong

    • Latvia

    • Mali

    • Malta

    • Mauritania

    • Mauritius

    • Monaco

    • Peru

    • Portugal

    • Romania

    • Senegal

    • Singapore

    • Switzerland

    • Togo

    • Tunisia

    • Turkey

    International Drug Name Search

    Minocycline ratiopharm




    Minocycline ratiopharm may be available in the countries listed below.


    Ingredient matches for Minocycline ratiopharm



    Minocycline

    Minocycline hydrochloride (a derivative of Minocycline) is reported as an ingredient of Minocycline ratiopharm in the following countries:


    • Netherlands

    International Drug Name Search

    Andriol-T




    Andriol-T may be available in the countries listed below.


    Ingredient matches for Andriol-T



    Testosterone

    Testosterone 17ß-decanoate & 17ß-isocaproate & 17ß-propionate & 17ß-phenp (a derivative of Testosterone) is reported as an ingredient of Andriol-T in the following countries:


    • Portugal

    International Drug Name Search

    Sunday 11 July 2010

    Osteofene




    Osteofene may be available in the countries listed below.


    Ingredient matches for Osteofene



    Alendronic Acid

    Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Osteofene in the following countries:


    • Argentina

    International Drug Name Search

    Wednesday 7 July 2010

    Lévothyrox




    Lévothyrox may be available in the countries listed below.


    Ingredient matches for Lévothyrox



    Levothyroxine

    Levothyroxine is reported as an ingredient of Lévothyrox in the following countries:


    • Tunisia

    Levothyroxine sodium salt (a derivative of Levothyroxine) is reported as an ingredient of Lévothyrox in the following countries:


    • France

    International Drug Name Search

    Tuesday 6 July 2010

    Sintopen




    Sintopen may be available in the countries listed below.


    Ingredient matches for Sintopen



    Amoxicillin

    Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Sintopen in the following countries:


    • Italy

    International Drug Name Search

    Friday 25 June 2010

    Fluocinolone (acétonide de)




    Fluocinolone (acétonide de) may be available in the countries listed below.


    Ingredient matches for Fluocinolone (acétonide de)



    Fluocinolone

    Fluocinolone (acétonide de) (DCF) is known as Fluocinolone in the US.

    International Drug Name Search

    Glossary

    DCFDénomination Commune Française

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Wednesday 23 June 2010

    Bufferin




    In the US, Bufferin (aspirin systemic) is a member of the following drug classes: platelet aggregation inhibitors, salicylates and is used to treat Angina, Angina Pectoris Prophylaxis, Ankylosing Spondylitis, Antiphospholipid Syndrome, Aseptic Necrosis, Back Pain, Fever, Heart Attack, Ischemic Stroke, Ischemic Stroke - Prophylaxis, Juvenile Rheumatoid Arthritis, Kawasaki Disease, Myocardial Infarction - Prophylaxis, Niacin Flush, Osteoarthritis, Pain, Prosthetic Heart Valves, Prosthetic Heart Valves - Mechanical Valves, Revascularization Procedures - Prophylaxis, Rheumatic Fever, Rheumatoid Arthritis, Sciatica, Systemic Lupus Erythematosus and Thromboembolic Stroke Prophylaxis.

    US matches:

    • Bufferin

    • Bufferin Arthritis Strength

    • Bufferin Extra Strength

    Ingredient matches for Bufferin



    Aspirin

    Acetylsalicylic Acid is reported as an ingredient of Bufferin in the following countries:


    • Greece

    • Japan

    • Oman

    • Peru

    • United States

    International Drug Name Search

    Monday 21 June 2010

    Omeprazol-1A Pharma




    Omeprazol-1A Pharma may be available in the countries listed below.


    Ingredient matches for Omeprazol-1A Pharma



    Omeprazole

    Omeprazole is reported as an ingredient of Omeprazol-1A Pharma in the following countries:


    • Austria

    • Estonia

    • Germany

    • Hungary

    • Switzerland

    International Drug Name Search

    Wednesday 16 June 2010

    Coagulation Factor VIII , Human (rDNA)




    Scheme

    Ph. Eur.

    ATC (Anatomical Therapeutic Chemical Classification)

    B02BD02

    Therapeutic Categories

    Hemostatic agent

    Blood coagulation factor substitute

    Foreign Names

    • Factor VIII coagulationis humanus (ADNr) (Latin)
    • Blutgerinnungsfaktor VIII (rDNA) vom Menschen (German)
    • Facteur VIII de coagulation humain (ADNr) (French)

    Generic Names

    • Antihemophilic factor VIII, recombinant human (IS)
    • Coagulation Factor VIII, Recombinant (IS)
    • Factor VIII (IS: rDNA)
    • rAHF (IS)
    • Blutgerinnungsfaktor VIII (rDNA) vom Menschen (PH: Ph. Eur. 6)
    • Dried Factor VIII (rDNA) (PH: BP 2010)
    • Facteur VIII de coagulation humain (ADNr) (PH: Ph. Eur. 6)
    • Factor VIII coagulationis humanus (ADNr) (PH: Ph. Eur. 6)
    • Human coagulation factor VIII (rDNA) (PH: Ph. Eur. 6)
    • Moroctocog Alfa (OS: BAN, DCF)
    • Octocog Alfa (OS: BAN, DCF)
    • Octocog Alfa (Genetical Recombination) (OS: JAN)
    • Blood-coagulation factor VIII (human), glycoform α (IS)
    • Rurioctocog Alfa (Genetical Recombination) (OS: JAN)
    • Ruriokutokoguarufa (IS)

    Brand Names

    • Advate
      Baxter, Slovenia


    • Recombinate
      Baxter, Slovenia


    • ReFacto
      Biovitrum, Norway; Wyeth, Austria; Wyeth, Australia; Wyeth, Belgium; Wyeth, Czech Republic; Wyeth, Germany; Wyeth, Denmark; Wyeth, Spain; Wyeth, Finland; Wyeth, France; Wyeth, Greece; Wyeth, Hungary; Wyeth, Iceland; Wyeth, Italy; Wyeth, Luxembourg; Wyeth, Netherlands; Wyeth, Norway; Wyeth, New Zealand; Wyeth, Portugal; Wyeth, Slovenia; Wyeth, Slovakia; Wyeth, United States; Wyeth Pharmaceuticals, United Kingdom


    • ReFacto AF
      Biovitrum, Sweden; Pfizer, Switzerland; Wyeth, Sweden


    • 8Y Factor VIII
      Sodhan, Turkey


    • 8Y
      Galenica, Greece; Paylos, Argentina


    • Aafact
      Sanquin, Netherlands


    • Advate
      Baxter, Austria; Baxter, Australia; Baxter, Belgium; Baxter, Canada; Baxter, Switzerland; Baxter, Czech Republic; Baxter, Germany; Baxter, Denmark; Baxter, Spain; Baxter, Finland; Baxter, France; Baxter, United Kingdom; Baxter, Greece; Baxter, Hungary; Baxter, Iceland; Baxter, Luxembourg; Baxter, Netherlands; Baxter, Norway; Baxter, New Zealand; Baxter, Slovakia; Baxter, United States; Baxter-RM, Italy


    • ADVATE
      Baxter, Sweden


    • Antihemophilic Factor
      Teva, Israel


    • Berirab
      IFET, Greece


    • Biostate
      CSL Limited Bioplasma Division, Australia


    • Czynnik VIII
      Imed, Poland


    • Dried Factor VIII Fraction
      BPL, Bahrain; BPL, Lithuania; BPL, Latvia; BPL, Malta; BPL, Oman


    • Emoclot D.I.
      Kedrion, Bosnia & Herzegowina; Kedrion, Georgia; Kedrion, Serbia; Pharma Riace, Russian Federation


    • Emoclot
      Kedrion, Bulgaria; Kedrion, Italy; Kedrion, Malta; Onko-Koçsel, Turkey


    • Factane
      CAF-DCF, Belgium; Er-Kim, Turkey; L.F.B., Luxembourg; LFB, France; LFB, Tunisia


    • Feiba
      Baxter, Bulgaria


    • Fibrogammin
      IFET, Greece


    • Haemate P (Coagulation Factor VIII , Human (rDNA) and Von Willebrand Factor)
      ZLB Behring, Belgium


    • Helixate Nexgen
      Csl Behring, Spain; Csl Behring, France


    • Helixate
      Bayer, Belgium; Bayer, Denmark; Bayer, Greece; Bayer, Iceland; Bayer, United States; Bayer AG, Luxembourg; Bayer Healthcare, Austria; Bayer Schering, Netherlands; Bayer-D, Italy; CSL Behring, Canada; CSL Behring, Switzerland; CSL Behring, Germany; CSL Behring, United States


    • Helixate NexGen
      CSL Behring, United Kingdom; CSL Behring, Norway; CSL Behring, Sweden


    • Immunate
      Baxter, Estonia


    • Kogenate Bayer
      Bayer, Bulgaria; Bayer, Czech Republic; Bayer, Germany; Bayer, Denmark; Bayer, Spain; Bayer, Finland; Bayer, Greece; Bayer, Croatia (Hrvatska); Bayer, Ireland; Bayer, Norway; Bayer, Slovenia; Bayer Healthcare, Austria; Bayer Santé, France; Bayer Schering, Netherlands


    • KOGENATE Bayer
      Bayer, Sweden


    • Kogenate
      Bayer, Belgium; Bayer, Canada; Bayer, Germany; Bayer, United Kingdom; Bayer, Hungary; Bayer, Ireland; Bayer, Italy; Bayer, New Zealand; Bayer, Portugal; Bayer, Taiwan; Bayer, United States; Bayer AG, Luxembourg; Schering, Georgia


    • Kogenate FS
      Bayer Schering, Indonesia; Bayer Yakuhin, Japan


    • Kogenate SF
      Bayer, Switzerland


    • Octanate
      Octapharm, Belgium


    • Octocog Alpha Bayer
      Bayer, Switzerland


    • Recombinate Lyfjaver
      Lyfjaver, Iceland


    • Recombinate
      Agmar, Croatia (Hrvatska); Baxter, Argentina; Baxter, Australia; Baxter, Belgium; Baxter, Switzerland; Baxter, Germany; Baxter, Denmark; Baxter, Finland; Baxter, France; Baxter, Greece; Baxter, Hong Kong; Baxter, Hungary; Baxter, Iceland; Baxter, Lithuania; Baxter, Luxembourg; Baxter, Latvia; Baxter, New Zealand; Baxter, Sweden; Baxter, Slovakia; Baxter, Taiwan; Baxter, United States; Baxter Healthcare-USA, Italy


    • Tisseel Lyo (Coagulation Factor VIII , Human (rDNA) and Fibrinogen)
      Baxter, Switzerland


    • Wilate (Coagulation Factor VIII , Human (rDNA) and Von Willebrand Factor)
      Octapharm, Belgium


    • Xyntha
      Wyeth, United States


    • Advate
      Baxter, Japan


    • Recombinate
      Baxter, Japan

    International Drug Name Search

    Glossary

    BANBritish Approved Name
    DCFDénomination Commune Française
    ISInofficial Synonym
    JANJapanese Accepted Name
    OSOfficial Synonym
    PHPharmacopoeia Name
    Ph. Eur.European Pharmacopoeia

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Faxilin




    Faxilin may be available in the countries listed below.


    Ingredient matches for Faxilin



    Flucloxacillin

    Flucloxacillin is reported as an ingredient of Faxilin in the following countries:


    • Bangladesh

    International Drug Name Search

    Saturday 12 June 2010

    Influenza A Medications


    Definition of Influenza A: A contagious viral infection of the nose, throat and lungs which often occurs in the winter.

    Drugs associated with Influenza A

    The following drugs and medications are in some way related to, or used in the treatment of Influenza A. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





    Drug List:

    Cartivix




    Cartivix may be available in the countries listed below.


    Ingredient matches for Cartivix



    Diacerein

    Diacerein is reported as an ingredient of Cartivix in the following countries:


    • Portugal

    International Drug Name Search

    Thursday 10 June 2010

    Haloperidol-neuraxpharm




    Haloperidol-neuraxpharm may be available in the countries listed below.


    Ingredient matches for Haloperidol-neuraxpharm



    Haloperidol

    Haloperidol is reported as an ingredient of Haloperidol-neuraxpharm in the following countries:


    • Germany

    International Drug Name Search

    Monday 7 June 2010

    Atox II ComboPen




    Atox II ComboPen may be available in the countries listed below.


    Ingredient matches for Atox II ComboPen



    Atropine

    Atropine is reported as an ingredient of Atox II ComboPen in the following countries:


    • Switzerland

    Obidoxime Chloride

    Obidoxime Chloride is reported as an ingredient of Atox II ComboPen in the following countries:


    • Switzerland

    International Drug Name Search

    Sunday 6 June 2010

    Premature Atrial Depolarizations Medications


    There are currently no drugs listed for "Premature Atrial Depolarizations". See Arrhythmia.





    Drug List:

    Oxiconazole




    Scheme

    Rec.INN

    ATC (Anatomical Therapeutic Chemical Classification)

    D01AC11,G01AF17

    CAS registry number (Chemical Abstracts Service)

    0064211-45-6

    Chemical Formula

    C18-H13-Cl4-N3-O

    Molecular Weight

    429

    Therapeutic Category

    Antifungal agent

    Chemical Name

    Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, O-[(2,4-dichlorophenyl)methyl]oxime, (Z)-

    Foreign Names

    • Oxiconazolum (Latin)
    • Oxiconazol (German)
    • Oxiconazole (French)
    • Oxiconazol (Spanish)

    Generic Names

    • Oxiconazole (OS: BAN, DCF)
    • Ro 13-8996/000 (IS)
    • Oxiconazole Nitrate (OS: BANM, JAN, USAN)
    • Ro 13-8996/001 (IS)
    • Sgd 301-76 (IS: Siegfried)
    • ST 813 (IS: Boehringer Ingelheim)

    Brand Names

    • Oceral
      Roche, Turkey


    • Oxistat
      Pharmaderm, United States


    • Fonx
      Astellas, France


    • Myfungar
      Taurus, Germany; Zentiva, Czech Republic; Zentiva, Russian Federation; Zentiva, Slovakia


    • Oceral
      Bayer, Brazil; Teva Pharma, Switzerland


    • Okiconale V
      Fuji Yakuhin, Japan


    • Okinazole
      Tanabe Mitsubishi, Japan


    • Okinazole V
      Tanabe Mitsubishi, Japan


    • Oxipelle
      Valeant, Brazil


    • Oxistat
      GlaxoSmithKline, Mexico; GlaxoSmithKline, United States


    • Salongo
      Biosarto, Spain

    International Drug Name Search

    Glossary

    BANBritish Approved Name
    BANMBritish Approved Name (Modified)
    DCFDénomination Commune Française
    ISInofficial Synonym
    JANJapanese Accepted Name
    OSOfficial Synonym
    Rec.INNRecommended International Nonproprietary Name (World Health Organization)
    USANUnited States Adopted Name

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Tuesday 1 June 2010

    Akamon




    Akamon may be available in the countries listed below.


    Ingredient matches for Akamon



    Bromazepam

    Bromazepam is reported as an ingredient of Akamon in the following countries:


    • Cyprus

    • Hong Kong

    • Iraq

    • Jordan

    • Malta

    • Sudan

    • Taiwan

    • Yemen

    International Drug Name Search

    Wednesday 26 May 2010

    Chemicon




    Chemicon may be available in the countries listed below.


    Ingredient matches for Chemicon



    Ketoconazole

    Ketoconazole is reported as an ingredient of Chemicon in the following countries:


    • Ecuador

    International Drug Name Search

    Tuesday 25 May 2010

    Ogestrel




    In the US, Ogestrel (ethinyl estradiol/norgestrel systemic) is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Emergency Contraception, Endometriosis and Gonadotropin Inhibition.

    US matches:

    • Ogestrel

    • Ogestrel-28

    Ingredient matches for Ogestrel



    Ethinylestradiol

    Ethinylestradiol is reported as an ingredient of Ogestrel in the following countries:


    • United States

    Norgestrel

    Norgestrel is reported as an ingredient of Ogestrel in the following countries:


    • United States

    International Drug Name Search

    Sunday 23 May 2010

    Izobidodici




    Izobidodici may be available in the countries listed below.


    In some countries, this medicine may only be approved for veterinary use.

    Ingredient matches for Izobidodici



    Cyanocobalamin

    Cyanocobalamin is reported as an ingredient of Izobidodici in the following countries:


    • Italy

    International Drug Name Search

    Wednesday 19 May 2010

    Sulfasalazin medac




    Sulfasalazin medac may be available in the countries listed below.


    Ingredient matches for Sulfasalazin medac



    Sulfasalazine

    Sulfasalazine is reported as an ingredient of Sulfasalazin medac in the following countries:


    • Denmark

    • Finland

    • Germany

    • Sweden

    International Drug Name Search

    Tuesday 18 May 2010

    Ofloxacino Combix




    Ofloxacino Combix may be available in the countries listed below.


    Ingredient matches for Ofloxacino Combix



    Ofloxacin

    Ofloxacin is reported as an ingredient of Ofloxacino Combix in the following countries:


    • Spain

    International Drug Name Search

    Monday 17 May 2010

    Rhinonorm




    Rhinonorm may be available in the countries listed below.


    Ingredient matches for Rhinonorm



    Xylometazoline

    Xylometazoline hydrochloride (a derivative of Xylometazoline) is reported as an ingredient of Rhinonorm in the following countries:


    • Russian Federation

    International Drug Name Search

    Saturday 15 May 2010

    Alenstran




    Alenstran may be available in the countries listed below.


    Ingredient matches for Alenstran



    Cetirizine

    Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Alenstran in the following countries:


    • Greece

    International Drug Name Search

    Omeprazol ITF




    Omeprazol ITF may be available in the countries listed below.


    Ingredient matches for Omeprazol ITF



    Omeprazole

    Omeprazole is reported as an ingredient of Omeprazol ITF in the following countries:


    • Portugal

    International Drug Name Search

    Saturday 8 May 2010

    Diphenhydramine Hydrochloride




    Ingredient matches for Diphenhydramine Hydrochloride



    Diphenhydramine

    Diphenhydramine Hydrochloride (BANM) is known as Diphenhydramine in the US.

    International Drug Name Search

    Glossary

    BANMBritish Approved Name (Modified)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Ogestrel


    Pronunciation: nor-JES-trel/ETH-in-il es-tra-DYE-ole
    Generic Name: Norgestrel/Ethinyl Estradiol
    Brand Name: Examples include Lo/Ovral and Ogestrel

    Smoking cigarettes while using Ogestrel increases your chance of having heart problems. Do not smoke while using Ogestrel. The risk of heart problems increases with age and with frequent smoking. Women older than 35 years of age and women who smoke 15 or more cigarettes per day are at a greater risk for heart problems.





    Ogestrel is used for:

    Preventing pregnancy. It may also be used for other conditions as determined by your doctor.


    Ogestrel is a combination birth control pill. It works by preventing ovulation, altering the cervical mucus, and changing the lining of the uterus.


    Do NOT use Ogestrel if:


    • you are allergic to any ingredient in Ogestrel

    • you have a history of blood clotting problems; heart disease; irregular heartbeat due to clotting problems; blood vessel problems (eg, blood flow problems in the brain or heart, stroke); chest pain (eg, heart attack, angina); certain types of headaches or migraines; uncontrolled high blood pressure; diabetes that affects circulation; breast cancer; endometrial, cervical, or vaginal cancer; estrogen-dependent growths; undiagnosed vaginal bleeding; yellowing of the eyes or skin due to pregnancy or prior birth control use; or liver disease or tumors

    • you know or suspect that you are pregnant

    • you have had surgery and are confined to a bed or a chair for an extended period of time

    Contact your doctor or health care provider right away if any of these apply to you.



    Before using Ogestrel:


    Some medical conditions may interact with Ogestrel. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


    • if you are pregnant, planning to become pregnant, or are breast-feeding

    • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

    • if you have allergies to medicines, foods, or other substances

    • if you have endometriosis, growths in the uterus, abnormal mammogram, irregular menstrual periods, a lump in the breast, heart problems, diabetes, headaches or migraines, gallbladder problems, high blood pressure, high blood cholesterol or lipid levels, kidney problems, blood problems (eg, porphyria), blood in the urine, depression or other mental/mood problems, lupus, chorea, high blood calcium levels, yellowing of the eyes or skin, pancreas problems (eg, pancreatitis), seizures (eg, epilepsy), or a history of cancer

    • if you are overweight, you have not yet had your first menstrual period, or you use tobacco

    Some MEDICINES MAY INTERACT with Ogestrel. Tell your health care provider if you are taking any other medicines, especially any of the following:


    • Aprepitant, azole antifungals (eg, ketoconazole, itraconazole), barbiturates (eg, phenobarbital), bosentan, carbamazepine, dexamethasone, felbamate, griseofulvin, HIV protease inhibitors (eg, ritonavir), hydantoins (eg, phenytoin), modafinil, nevirapine, oxcarbazepine, penicillins (eg, amoxicillin), rifabutin, rifampin, phenylbutazone, primidone, tetracyclines (eg, doxycycline), topiramate, troglitazone, or St. John's wort because the effectiveness of Ogestrel may be decreased, resulting in breakthrough bleeding or pregnancy

    • Atorvastatin, indinavir, or troleandomycin because they may increase the risk of Ogestrel's side effects.

    • Beta-blockers (eg, propranolol), corticosteroids (eg, prednisolone), cyclosporine, or theophylline because the risk of their side effects may be increased by Ogestrel

    • Clofibric acid, morphine, lamotrigine, salicylic acid, or temazepam because their effectiveness may be decreased by Ogestrel

    This may not be a complete list of all interactions that may occur. Ask your health care provider if Ogestrel may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


    How to use Ogestrel:


    Use Ogestrel as directed by your doctor. Check the label on the medicine for exact dosing instructions.


    • Take Ogestrel by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

    • Begin taking Ogestrel on the first Sunday following the start of your period, unless otherwise directed by your doctor. If your period begins on a Sunday, begin taking Ogestrel on that day. Try to take Ogestrel at the same time every day, not more than 24 hours apart. After taking the last pill in the pack, start taking the first pill from a new pack the very next day.

    • Ogestrel works best if it is taken at the same time each day. Do not skip doses.

    • If you miss 1 dose of Ogestrel, take it as soon as you remember. Take your next dose at the regular time. This means you may take 2 doses on the same day. If you miss more than 1 dose of Ogestrel, read the extra patient information leaflet that comes with Ogestrel or contact your doctor for instructions. If you miss 1 or more doses of Ogestrel, you must use a backup form of birth control for 7 days after you start to take it again. If you are not sure about how to handle miss doses, use an extra form of birth control (eg, condoms) and talk with your doctor.

    Ask your health care provider any questions you may have about how to use Ogestrel.



    Important safety information:


    • Ogestrel may cause dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Ogestrel with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

    • Follow your doctor's instructions for examining your own breasts and report any lumps immediately.

    • If you will be having surgery or will be confined to a bed or chair for a long period of time (such as a long plane flight), notify your doctor 3 to 4 weeks ahead of time. Special precautions may need to be taken in these circumstances while taking Ogestrel.

    • Ogestrel may cause dark skin patches on your face. Exposure to the sun may make these patches darker. If patches develop, use a sunscreen or protected clothing when exposed to the sun, sunlamps, or tanning booths.

    • Use of Ogestrel will not prevent the spread of sexually transmitted diseases (STDs).

    • Bleeding or spotting may occur while taking Ogestrel. Do not stop taking Ogestrel if this occurs. If bleeding or spotting continues for more than 7 days or is heavy, contact your doctor.

    • Ogestrel may increase the risk of stroke, heart attack, blood clots, high blood pressure, or similar problems. The risk may be greater if you smoke.

    • Ogestrel may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Ogestrel.

    • Taking certain antibiotics, anticonvulsants, or other medicines, as listed in the interactions section, while you are using Ogestrel may decrease the effectiveness of Ogestrel. To prevent pregnancy, use an extra form of birth control until your next period.

    • If you wear contact lens and you develop problems with them, contact your doctor.

    • If you miss your period during the week of inactive pills, call your doctor immediately. A missed period may indicate that you are pregnant.

    • Ogestrel may take time to wear off after your last dose. You may not be able to become pregnant for several months after stopping Ogestrel. Discuss any concerns with your doctor or pharmacist.

    • Lab tests, including PAP tests, may be performed while you use Ogestrel. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

    • Ogestrel is not recommended for use in CHILDREN who have not had their first menstrual period. Safety and effectiveness in this age group have not been confirmed.

    • PREGNANCY and BREAST-FEEDING: Do not use Ogestrel if you are pregnant. If you think you may be pregnant, contact your doctor right away. Ogestrel is found in breast milk. Do not breast-feed while taking Ogestrel.


    Possible side effects of Ogestrel:


    All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



    Acne; breast tenderness or enlargement; changes in appetite; changes in weight; dizziness; headache; mild hair loss; nausea; nervousness; stomach cramps or bloating; vaginal spotting or breakthrough bleeding.



    Seek medical attention right away if any of these SEVERE side effects occur:

    Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue, unusual hoarseness); absent menstrual period; breast discharge; breast lumps; calf or leg pain, swelling, or tenderness; change in the amount of urine produced; chest pain or heaviness; confusion; coughing of blood; dark urine; fainting; mental or mood changes (eg, depression); migraines; numbness of an arm or leg; one-sided weakness; pale stools; persistent, severe, or recurring headache or dizziness; persistent vaginal spotting; severe pain or tenderness in the stomach; shortness of breath; slurred speech; sudden severe headache or vomiting; swelling of the fingers, hands, legs, or ankles; unusual or severe vaginal bleeding; unusual tiredness or weakness; vaginal irritation, discharge, or change in secretions; vision changes (eg, sudden vision loss, double vision); yellowing of the skin or eyes (with or without fever).



    This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


    See also: Ogestrel side effects (in more detail)


    If OVERDOSE is suspected:


    Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include nausea; vaginal bleeding; vomiting.


    Proper storage of Ogestrel:

    Store Ogestrel at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ogestrel out of the reach of children and away from pets.


    General information:


    • If you have any questions about Ogestrel, please talk with your doctor, pharmacist, or other health care provider.

    • Ogestrel is to be used only by the patient for whom it is prescribed. Do not share it with other people.

    • If your symptoms do not improve or if they become worse, check with your doctor.

    • Check with your pharmacist about how to dispose of unused medicine.

    This information is a summary only. It does not contain all information about Ogestrel. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



    Issue Date: February 1, 2012

    Database Edition 12.1.1.002

    Copyright © 2012 Wolters Kluwer Health, Inc.

    More Ogestrel resources


    • Ogestrel Side Effects (in more detail)
    • Ogestrel Use in Pregnancy & Breastfeeding
    • Ogestrel Drug Interactions
    • Ogestrel Support Group
    • 0 Reviews for Ogestrel - Add your own review/rating


    Compare Ogestrel with other medications


    • Abnormal Uterine Bleeding
    • Birth Control
    • Emergency Contraception
    • Endometriosis
    • Gonadotropin Inhibition